Genomics in Cancer Drug Discovery and Development

Status

Published

on 12 Oct 2009

Year of Creation

2006

Elsevier Inc

Registration Number

TX0007094999

on 12 Oct 2009

The U.S. Copyright record (Registration Number: TX0007094999) dated 12 Oct 2009, pertains to an electronic file (eService) titled "Genomics in Cancer Drug Discovery and Development" created in 2006. The copyright holder is Elsevier Inc, known for their creative contributions in text registration. For any inquiries concerning this copyrighted material, kindly reach out to Elsevier Inc.

Elsevier Inc

Application Details

Registration Number

TX0007094999

Registration Date

10/12/2009

Year of Creation

2006

Agency Marc Code

DLC-CO

Record Status

New

Corporate Author

Elsevier Inc

Physical Description

Book, 409 p

First Publication Nation

United States

ISBN

9780120066964

Preexisting Material

permissioned material and material from the public domain

Corporate Authors

Elsevier Inc

Notes

Rights Note: Elsevier Inc, 525 B Street, Suite 1900, San Diego, CA, 92101, United States

Material Matter Claimed Note: text, photographs, artwork

Statements

Application Title Statement: Genomics in Cancer Drug Discovery and Development

Author Statement: Elsevier Inc employer for hire Domicile: United States Citizenship: United States Authorship: text, photograph(s), artwork

Notes

Rights Note: Elsevier Inc, 525 B Street, Suite 1900, San Diego, CA, 92101, United States

Material Matter Claimed Note: text, photographs, artwork

Statements

Application Title Statement: Genomics in Cancer Drug Discovery and Development

Author Statement: Elsevier Inc employer for hire Domicile: United States Citizenship: United States Authorship: text, photograph(s), artwork

Get your copyright registered todayThousands have copyrighted their assets.
What are you waiting for?

Show terms & conditions

Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.